5. Prevalence of maternal complications and associated factors among women with hypertensive disorders in pregnancy at national hospital of obstetrics and gynecology
Main Article Content
Abstract
The aim of this study was to assess the prevalence of maternal complications and identify factors associated with adverse maternal outcomes among women with hypertensive disorders in pregnancy (HDP) in Vietnam. A cross-sectional study was conducted with 206 women with HDP who delivered at National Hospital of Obstetrics and Gynecology between March 2023 and July 2023. Regarding maternal adverse outcomes, HELLP syndrome (3.4%), eclampsia (1.5%), and placental abruption (1.5%) were the three most common complications. There were no maternal deaths. Bivariate logistic regressions showed that platelet count, proteinuria, AST, ALT, Creatinine, and severity symptoms were associated with adverse maternal outcomes. In the multiple logistic regression model, platelet count, proteinuria, AST were independent predictors of adverse maternal outcomes. The prevalence of maternal complications in our study was lower than the rates reported in some previous studies. Severity symptoms and abnormal laboratory test results significantly increased the risk of developing maternal complications among women with HDP.
Article Details
Keywords
Hypertensive disorders in pregnancy, associated factor, adverse maternal outcomes
References
2. von Dadelszen P, Magee LA. Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016; 36: 83-102. doi:10.1016/j.bpobgyn.2016.05.005.
3. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122 (5): 1122-1131. doi:10.1097/01.AOG.0000437382.03963.88.
4. Mersha AG, Abegaz TM, Seid MA. Maternal and perinatal outcomes of hypertensive disorders of pregnancy in Ethiopia: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019; 19(1): 458. doi:10.1186/s12884-019-2617-8.
5. Kumar M, Singh A, Garg R, Goel M, Ravi V. Hypertension during pregnancy and risk of stillbirth: challenges in a developing country. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2021; 34(23): 3915-3921. doi:10.1080/14767058.2019.1702943.
6. Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk Factors of Pre-Eclampsia/Eclampsia and Its Adverse Outcomes in Low- and Middle-Income Countries: A WHO Secondary Analysis. PLOS ONE. 2014; 9(3): e91198. doi:10.1371/journal.pone.0091198.
7. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020; 135(6): e237. doi:10.1097/AOG.0000000000003891.
8. Syoum FH, Abreha GF, Teklemichael DM, Chekole MK. Fetomaternal Outcomes and Associated Factors among Mothers with Hypertensive Disorders of Pregnancy in Suhul Hospital, Northwest Tigray, Ethiopia. J Pregnancy. 2022; 2022: 6917009. doi:10.1155/2022/6917009.
9. Panda S, Das R, Sharma N, Das A, Deb P, Singh K. Maternal and Perinatal Outcomes in Hypertensive Disorders of Pregnancy and Factors Influencing It: A Prospective Hospital-Based Study in Northeast India. Cureus. 2021; 13(3): e13982. doi:10.7759/cureus.13982.
10. Lugobe HM, Muhindo R, Kayondo M, et al. Risks of adverse perinatal and maternal outcomes among women with hypertensive disorders of pregnancy in southwestern Uganda. Horey DE, ed. PLOS ONE. 2020; 15(10): e0241207. doi:10.1371/journal.pone.0241207.
11. Wagnew M, Dessalegn M, Worku A, Nyagero J. Trends of preeclampsia/eclampsia and maternal and neonatal outcomes among women delivering in addis ababa selected government hospitals, Ethiopia: a retrospective cross-sectional study. Pan Afr Med J. 2016; 25(Suppl 2): 12. doi:10.11604/pamj.supp.2016.25.2.9716.
12. Obsa M, Wolka Woticha E, Girma Weji B, et al. Neonatal and Fetal Outcomes of Pregnant Mothers with Hypertensive Disorder of Pregnancy at Hospitals in Wolaita Zone, Southern Ethiopia. J Midwifery Reprod Health. 2019; 7(2): 1636-1640. doi:10.22038/jmrh.2018.29240.1315.
13. Singh R. Prediction by Full Preeclampsia Integrated Estimate of Risk Model in Preeclampsia Patients for Adverse Maternal and Neonatal Outcomes. J South Asian Fed Obstet Gynaecol. 2023; 15(2): 182-187. doi:10.5005/jp-journals-10006-2212.
14. Lv B, Zhang Y, Yuan G, et al. Establishment of a nomogram model for predicting adverse outcomes in advanced-age pregnant women with preterm preeclampsia. BMC Pregnancy Childbirth. 2022; 22(1): 221. doi:10.1186/s12884-022-04537-x.
15. Kozic JR, Benton SJ, Hutcheon JA, et al. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. 2011; 33(10): 995-1004. doi:10.1016/S1701-2163(16)35048-4.
16. Thangaratinam S, Gallos ID, Meah N, et al. How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2011; 90(6): 564-573. doi:10.1111/j.1600-0412.2011.01111.x.
17. Bouzari Z, Javadiankutenai M, Darzi A, Barat S. Does proteinura in preeclampsia have enough value to predict pregnancy outcome? Clin Exp Obstet Gynecol. 2014; 41(2): 163-168.
18. Ukah UV, De Silva DA, Payne B, et al. Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertens. 2018; 11: 115-123. doi:10.1016/j.preghy.2017.11.006.
19. National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. RCOG Press; 2010. Accessed June 23, 2023. http://www.ncbi.nlm.nih.gov/books/NBK62652/
20. von Dadelszen P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet Lond Engl. 2011; 377(9761): 219-227. doi:10.1016/S0140-6736(10)61351-7.